Loading...

PLSE PULSE BIOSCIENCES INC Management Changes 8-K Filing

PLS

PLS

PULSE BIOSCIENCES INC

(PLSE)

2024 8-K

Show Summary

Show Summary

Financial Statements

Financial Results

CFO Appointment

Investor Update

CEO Appointment

Warrant Redemption

CEO Resignation

Stock Purchase Plan

Positive Study Results

Quarterly Results

Investor Update

Equity Distribution Agreement

FDA Breakthrough Device Des...

Rights Offering

Annual Meeting and Voting R...

Rights Offering

Rights Offering

Financial Results Announcement

Rights Offering

Financial Results and Right...

FDA Clearance Announcement

Investor Presentation

Stockholder Meeting

Programmatic Updates

Earnings Reports

Bonuses Approved

Earnings Reports

Public Disclosure

Departure of Directors

Financial Results Announcement

Redemption of Warrants

Private Placement

Compensation Changes

Private Placement Agreement

Financial Results and Manag...

Loan Agreement Amendment

External Links:

Pulse Biosciences, Inc. reported its financial results for the quarter ending September 30, 2024, and announced the appointment of David Kenigsberg, M.D. as Chief Medical Officer of Electrophysiology.

AI Assistant

PULSE BIOSCIENCES INC

2024

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.